Aditya Birla SL Quant Fund
The Scheme seeks to generate long term capital appreciation by investing in equity and equity related securities based on quant model theme. The Scheme does not guarantee/indicate any returns. There is no assurance that the investment objective of the Scheme will be achieved.
Growthvine rating: 3/5 — ranked #88 of 184 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹9.57 (as of 2026-10-01) |
|---|
| AUM | ₹2,037 Cr |
|---|
| Expense ratio | 1.76% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Harish Krishnan |
|---|
| Exit load | 0.5% for redemption within 90 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −23.44% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 69.1% of NIFTY Alpha 50's upside and 70.3% of its downside.
Market cap allocation
| Large cap | 51.8% |
|---|
| Mid cap | 42.8% |
|---|
| Small cap | 5.3% |
|---|
Concentration
| Top 5 holdings | 21.3% |
|---|
| Top 10 holdings | 39.5% |
|---|
| Total holdings | 40 |
|---|
Top holdings
- Marico Limited — 4.5%
- Torrent Pharmaceuticals Ltd. — 4.4%
- Nestle India Ltd. — 4.3%
- Federal Bank Ltd. — 4.1%
- Grasim Industries Ltd — 4.1%
- Apollo Hospitals Enterprises Ltd. — 4.0%
- State Bank Of India — 3.6%
- Laurus Labs Limited — 3.6%
- Sun Pharmaceutical Industries Ltd. — 3.5%
- Hindalco Industries Ltd. — 3.5%
Top sectors
- Pharma & Biotech — 19.4%
- Industrial Products — 11.5%
- Banking & Financial — 9.9%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −5.6% | Q3 | #100 of 167 |
| 2025 | 6.4% | Q2 | #45 of 132 |